Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural MesotheliomaIVANOVA, Alla V; GOPARAJU, Chandra M. V; IVANOV, Sergey V et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2602-2611, issn 1078-0432, 10 p.Article

Pemetrexed in malignant pleural mesotheliomaHAZARIKA, Maitreyee; WHITE, Robert M; MORSE, David E et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 982-992, issn 1078-0432, 11 p.Article

Validation of genomics-based prognostictests in malignant pleural mesotheliomaGORDON, Gavin J; ROCKWELL, Graham N; GODFREY, Paul A et al.Clinical cancer research. 2005, Vol 11, Num 12, pp 4406-4414, issn 1078-0432, 9 p.Article

Malignant pleural mesotheliomaCERESOLI, G. L; BETTA, G. P; CASTAGNETO, B et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, ii13-ii16, SUP2Conference Paper

Mésothéliome pleural malin : un regain d'intérêt = New attention to malignant pleural mesotheliomaLETONTURIER, Philippe.La Presse médicale (1983). 2007, Vol 36, Num 2, pp 255-256, issn 0755-4982, 2 p., CAH1Article

Mésothéliome pleuralAstoul, Philippe.2004, isbn 2-84299-437-X, 221 p., isbn 2-84299-437-XBook

Multimodal management of malignant pleural mesothelioma: where are we today?VAN SCHIL, Paul E; OPITZ, Isabelle; WEDER, Walter et al.The European respiratory journal. 2014, Vol 44, Num 3, pp 754-764, issn 0903-1936, 11 p.Article

The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesotheliomaPINATO, D. J; AMAURI, F; LLOYD, T et al.British journal of cancer. 2013, Vol 108, Num 3, pp 621-628, issn 0007-0920, 8 p.Article

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesotheliomaMELAIU, Ombretta; CRISTAUDO, Alfonso; MELISSARI, Erika et al.Mutation research. Reviews in mutation research. 2012, Vol 750, Num 2, pp 132-140, issn 1383-5742, 9 p.Article

Complete Response and Long-term Survival in Malignant Pleural Mesothelioma: Case ReportTAKANEN, Silvia; RESULI, Blerina; GRAZIANO, Vanessa et al.Anticancer research. 2012, Vol 32, Num 4, pp 1485-1487, issn 0250-7005, 3 p.Article

Clinical significance of pleural effusion mesothelin in malignant pleural mesotheliomaYAMADA, Shusai; TABATA, Chiharu; TABATA, Rie et al.Clinical chemistry and laboratory medicine. 2011, Vol 49, Num 10, pp 1721-1726, issn 1434-6621, 6 p.Article

Establishment of a cell line from a Japanese patient useful for generating an in vivo model of malignant pleural mesotheliomaSATO, Ayuko; TORII, Ikuko; TAO, Li-Hua et al.Cancer science. 2011, Vol 102, Num 3, pp 648-655, issn 1347-9032, 8 p.Article

Localized Malignant Lymphohistiocytoid Pleural MesotheliomaOUAZZANI, A; RONDELET, B; SOKOLOW, Y et al.Acta chirurgica belgica (Ed. bilingue). 2011, Num 1, pp 38-43, issn 0001-5458, 6 p.Article

Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor BurdenCREANEY, Jenette; FRANCIS, Roslyn J; DICK, Ian M et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1181-1189, issn 1078-0432, 9 p.Article

E7080, a Multi-Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production ProfilesIKUTA, Kenji; YANO, Seiji; UEHARA, Hisanori et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7229-7237, issn 1078-0432, 9 p.Article

Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesotheliomaSCHERPEREEL, Arnaud.Respiratory medicine. 2007, Vol 101, Num 6, pp 1265-1276, issn 0954-6111, 12 p.Article

L'immunothérapie dans le mésothéliome malin : perspectives thérapeutiques = Immunotherapy and malignant mesothelioma : clinical perspectivesGREGOIRE, Marc; EBSTEIN, Frédéric.Bulletin du cancer. 2007, Vol 94, Num 1, pp 23-31, issn 0007-4551, 9 p.Article

Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [⁸F]fluorodeoxyglucoseCERESOLI, Giovanni L; CHITI, Arturo; ZUCALI, Paolo A et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4587-4593, issn 0732-183X, 7 p.Article

Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesotheliomaHONGQIANG XIA; KARASAWA, Katsuyuki; HANYU, Nahoko et al.International journal of hyperthermia. 2006, Vol 22, Num 7, pp 613-621, issn 0265-6736, 9 p.Article

Prognostic value of pleural fluid ph in malignant epithelial mesothelioma after talc poudrageAELONY, Yossef; YAO, Janis F; KING, Randel R et al.Respiration (Basel). 2006, Vol 73, Num 3, pp 334-339, issn 0025-7931, 6 p.Article

Metastatic malignant pleural mesothelioma to the breastSHEEN-CHEN, Shyr-Ming; LIU, Yei-Wei; ENG, Hock-Liew et al.Southern medical journal (Birmingham). 2006, Vol 99, Num 12, pp 1395-1397, issn 0038-4348, 3 p.Article

Consensus report : Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomaVAN MEERBEECK, Jan P; BOYER, Michael.Lung cancer. 2005, Vol 49, pp S123-S127, issn 0169-5002, SUP1Conference Paper

Extended surgical staging for potentially resectable malignant pleural mesothelioma. DiscussionRICE, David C; ERASMUS, Jeremy J; SMYTHE, W. Roy et al.The Annals of thoracic surgery. 2005, Vol 80, Num 6, pp 1988-1993, issn 0003-4975, 6 p.Conference Paper

Malignant pleural mesothelioma metastasis to the mandibleTERAKADO, N; SHINTANI, S; NAKASHIRO, K et al.International journal of oral and maxillofacial surgery. 2004, Vol 33, Num 8, pp 798-800, issn 0901-5027, 3 p.Article

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesotheliomaGHANIM, B; HODA, M. A; SAMARZIJA, M et al.British journal of cancer. 2014, Vol 110, Num 4, pp 984-990, issn 0007-0920, 7 p.Article